Aplicação da versão em português do instrumento abreviado de avaliação da qualidade de vida "WHOQOL-bref"

Fleck, Marcelo Pio de Almeida; Louzada, Sérgio Noll; Xavier, Marta Kops; Chachamovich, Eduardo; Vieira, Guilherme M.; Santos, Lyssandra dos; Pinzon, Vanessa

doi:10.1590/s0034-89102000000200012

Supporting

Mentioning

685

Contrasting

Unclassified

882

Order By: Relevance

“…The questions related to the psychological domain deal with positive feelings; thinking and learning; self esteem; body image; negative feelings; and spirituality [9]. Women idealize and elaborate a body image surrounded by physiological, psychological and social aspects that affect the emotions, thoughts and the way of relating with other people, significantly influencing their quality of life, a fact observed in the present study.…”

Section: Discussionsupporting

“…The questions related to the social domain relate to personal relationships, support and sexual activity [9]. Interestingly, among the domains of the WHO-QOL-BREF in the present study, the social domain was the only one in which the mean scores showed an increase after the chemotherapy, even though small and without statistical significance, in relation to the mean scores before the women started the proposed chemotherapeutic treatment.…”

Section: Discussionmentioning

“…The Cronbach's alpha value ranged from 0 to 1, with the best levels of internal consistency being those closest to 1. It should be noted that the social domain has only three items, which implies impairment in the use of Cronbach's alpha for internal validity, since the recommended for this type of analysis is the presence of at least four items [9].…”

Section: Resultsmentioning

“…Regarding the environment domain, the WHO-QOL-BREF questions address physical security, the home environment, financial resources, health care, information, recreation and leisure, physical environment and transportation [9].…”

Section: Discussionmentioning

See 3 more Smart Citations

Quality Of Life Of Patients With Breast And Gynecological Cancer Faced With Anticancer Chemotherapy

Regino¹,

Elias²,

Silveira³

et al. 2017

int arch med

View full text Add to dashboard Buy / Rent full text

Background: The evaluation of quality of life in cancer patients is of interest to researchers due to its impact on health policies. The aim of this study was to assess the quality of life of patients with breast and gynecological cancer, undergoing chemotherapy. Methods and Findings:This was a quantitative, descriptive and longitudinal study, conducted in the Clinical Hospital of the Triangulo Mineiro Federal University. To assess the quality of life, the Portuguese brief version of the World Health Organization Quality of Life (WHO-QOL-BREF) instrument was applied. The paired Student's t-test was used for the analysis of the means of/ the scores of the domains. The study included 14 women. The lowest means were observed in the physical domain, 51.78±15.89 and 50.25±15.37, respectively before and after treatment. There was also a compromise of the psychological and environment domains, however, the data analyzed did not show statistical significance. The main limitation of this study is the sample size.

show abstract

Create an account to read the remaining citation statements from this report. You will also get access to:

Search over 1.2b+ citation statments to see what is being said about any topic in the research literature
Advanced Search to find publications that support or contrast your research
Citation reports and visualizations to easily see what publications are saying about each other
Browser extension to see Smart Citations wherever you read research
Dashboards to evaluate and keep track of groups of publications
Alerts to stay on top of citations as they happen
Automated reference checks to make sure you are citing reliable research in your manuscripts
7 day free preview of our premium features.

Trusted by researchers and organizations around the world

Over 130,000 students researchers, and industry experts at use scite

See what students are saying

Slide 1 of 4

scite is an incredibly clever tool. The feature that classifies papers on whether they find supporting or contrasting evidence for a particular publication saves so much time. It has become indispensable to me when writing papers and finding related work to cite and read.

Emir Efendić, Ph.D

Maastricht University

As a PhD student, I'm so glad that this exists for my literature searches and papers. Being able to assess what is disputed or affirmed in the literature is how the scientific process is supposed to work, and scite helps me do this more efficiently.

Kathleen C McCormick, Ph.D Student

Cornell

scite is such an awesome tool! It’s never been easier to place a scientific paper in the context of the wider literature.

Mark Mikkelsen, Ph.D

The Johns Hopkins University School of Medicine

This is a really cool tool. I just tried it out on a paper we wrote on flu/pneumococcal seasonality... really interesting to see the results were affirmed by other studies. I had no idea.

David N. Fisman, Ph.D

University of Toronto

Emir Efendić, Ph.D

Maastricht University

Kathleen C McCormick, Ph.D Student

Cornell

scite is such an awesome tool! It’s never been easier to place a scientific paper in the context of the wider literature.

Mark Mikkelsen, Ph.D

The Johns Hopkins University School of Medicine

This is a really cool tool. I just tried it out on a paper we wrote on flu/pneumococcal seasonality... really interesting to see the results were affirmed by other studies. I had no idea.

David N. Fisman, Ph.D

University of Toronto

Emir Efendić, Ph.D

Maastricht University

Kathleen C McCormick, Ph.D Student

Cornell

scite is such an awesome tool! It’s never been easier to place a scientific paper in the context of the wider literature.

Mark Mikkelsen, Ph.D

The Johns Hopkins University School of Medicine

This is a really cool tool. I just tried it out on a paper we wrote on flu/pneumococcal seasonality... really interesting to see the results were affirmed by other studies. I had no idea.

David N. Fisman, Ph.D

University of Toronto

Section: Discussionsupporting

Section: Discussionmentioning

Section: Resultsmentioning

Section: Discussionmentioning

See 2 more Smart Citations

Quality Of Life Of Patients With Breast And Gynecological Cancer Faced With Anticancer Chemotherapy

Regino¹,

Elias²,

Silveira³

et al. 2017

int arch med

View full text Add to dashboard Buy / Rent full text

show abstract

“…The WHOQOLBref is a 26-item measure taken from the larger WHOQOL-100 a multi-lingual assessment for generic quality of life, which was developed concurrently across fifteen international fields centers 22 . The 26 items of the WHOQOL-Bref distribute into four domains (physical, psychological, social relationships and environment) and are answered using individualized five-point scales.…”

Section: Instrumentsmentioning

A eficácia do milnaciprano em pacientes ambulatoriais com transtorno depressivo maior não respondedores ao tratamento com ISRSs: um estudo aberto de 12 semanas

Fleck,

Moreno²,

Andrade³

et al. 2010

Rev. psiquiatr. clín.

View full text Add to dashboard Buy / Rent full text

A eficácia do milnaciprano em pacientes ambulatoriais com transtorno depressivo maior não respondedores ao tratamento com ISRSs: um estudo aberto de 12 semanas Abstract Background: The objective of this study is to evaluate the efficacy of milnacipran in outpatients experiencing severe MDD non-respondent to adequate time and dosing of SSRI therapy. Methods: A 12 week multi-centric study open study was designed to evaluate the efficacy of milnacipran after a SRRI trial failure. Complete remission (HAMD-17 < 8) was the principal outcome. Secondary outcomes were response (HAM > 50%), CGI and quality of life measure (WHOQOLBref). Results: The mean HAMD-17 score of the sample was 27 (7.2). The remission rates for minalcipran were 17.5% and response 61.3%. At baseline, 70.9% of the patients were markedly or severely ill. At treatment end, 48.1% of the patients were normal asymptomatic or borderline and 20.2% were mildly ill. Also, the four domains of WHOQOL-Bref, a generic instrument of Quality of Life, presented statistical and clinical differences. Discussion: Our findings suggest that milnacipran is a possible option to be used in patients that were non-respondents to SSRIs. Since there is no evidence in literature that one single antidepressant is the best second step when an SSRI fail, milnacipran should be considered in the case of severe depressed patients.

show abstract

Aplicação da versão em português do instrumento abreviado de avaliação da qualidade de vida "WHOQOL-bref"

Quality Of Life Of Patients With Breast And Gynecological Cancer Faced With Anticancer Chemotherapy

Create an account to read the remaining citation statements from this report. You will also get access to:

Trusted by researchers and organizations around the world

Quality Of Life Of Patients With Breast And Gynecological Cancer Faced With Anticancer Chemotherapy

A eficácia do milnaciprano em pacientes ambulatoriais com transtorno depressivo maior não respondedores ao tratamento com ISRSs: um estudo aberto de 12 semanas

Contact Info

Product

Resources

About